Interestingly, ex vivo-differentiated B16-MDSCs were phenotypically equivalent to in vivo B16 melanoma intra-tumor MDSCs on representative markers, which included CD86, MHC II, CD62L, arginase-1 and PD-L1 (Supplementary Fig. S1). Here, ARG1 is linked to neoplasm.